Uric acid: pathophysiological implications

Authors: Fedor Šimko 1;  Andrej Dukát 2
Authors‘ workplace: Ústav patologickej fyziológie LF UK v Bratislave 1;  V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava 2
Published in: Forum Diab 2019; 8(1): 0


Pathophysiologic relations of hyperuricaemia are complex and associations are cinfirmed with cardiovascular, renal, methabolic diseases, endothelial dys-function, arterial hypertension, systemic inflammation, proaggregation and oxidative stress. From the first scientific report about hyperuricaemia in 1871 repeatedly causal relationship of increased uric acid level to several organism´s systems is described.


acid uric – hyperuricemia – pathophysiology

  1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011; 63(10): 3136–3141. Dostupné z DOI: <http://dx.doi.org/10.1002/art.30520>.
  2. Whelton A. Hyperuricemia and hypertension. A Confluence of Concepts. Editorial Commentary. Hypertension 2012; 60(5): 1112–1113. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.198341>.
  3. Gavorník P, Dukát A, Gašpar L et al. Klinický význam a liečba hyperurikémie. Slov Klin Pr 2007; 1(1): 18–20.
  4. Najmik P. Hyperurikémia. Súč Klin Prax 2007; 4(1): 14–18.
  5. Masuo K, Kawaguchi H, Mikami H at al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42(4): 474–480. Dostupné z DOI: <http://dx.doi.org/10.1161/01.HYP.0000091371.53502.D3>.
  6. Lai S, Mariotti A, Coppola B et al. Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease. Eur Rev Med Pharmacol Sci 2014; 18(7): 1010–1017.
  7. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenic role of uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41(4): 1183–1190. Dostupné z DOI: <http://dx.doi.org/10.1161/01.HYP.0000069700.62727.C5>.
  8. Tangri N, Weiner DE. Uric acid, CKD, and cardiovascular disease: confounders, culprits and circles. Am J Kidney Dis 2010; 56(2): 247–250. Dostupné z DOI: <http://dx.doi.org/10.1053/j.ajkd.2010.06.004>.
  9. Špinar J, Vítovec J, Pařenica J. Hypertenze a hyperurikemie. Vnitř Lék 2005; 51(1): 82–86.
  10. Kang DH, Nakagawa T, Feng L et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13(12): 2888–2897.
  11. Loeffler LF, Navas-Acien A, Brady TM et al. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999–2006. Hypertension 2012; 59(4): 811–817. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.183244>.
  12. Šimko F, Šimko J, Fábryová M. ACE-Inhibition and Angiotensin II Receptor Blockers in Chronic Heart Failure: Patophysiological Consideration of the Unresolved Battle. Cardiovasc Drugs Ther 2003; 17(3):287–280.
  13. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothe-lial dysfunction. Kidney Int 2005; 67(5): 1739–1742. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1523–1755.2005.00273.x>.
  14. Price KL, Sautin YY, Long DA et al. Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 2006; 17(7): 1791–1795. Dostupné z DOI: <http://dx.doi.org/10.1681/ASN.2006030264>.
  15. Keenan S. Relation of Uric Acid to Serum Levels of High-Sensitivity CRP, Triglycerides, and HDL-C and to Hepatic Steatosis. Am J Cardiol 2012; 110(12): 1787–1792. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjcard.2012.08.012>.
Diabetology Endocrinology Internal medicine
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account